BoniVein
Natural health product licensed in Canada
- Licence holder
- Viva Pharmaceutical Inc.
- NPN or DIN-HM
- 80086973
- Status
- Active licence
- Licence date
- 10 July 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 5-Hydroxy-2-(3-hydroxy-4-méthoxyphényl)-7-(O6-alpha-L-rhamnopyranosyl-bêta-D-glucopyranosyloxy)chromen-4-one Source : Citrus sinensis - Écorce de fruit | 150 milligramme | Not calculated |
| Ribes nigrum Source : Bourgeon floral Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 30 milligramme | 3 milligramme | Not calculated |
| Acide L-ascorbique Source : Acide ascorbique | 100 milligramme | Not calculated |
| 3,3',4',5,7-Pentahydroxyflavone-3-rutinoside Source : Styphnolobium japonicum - fleur | 400 milligramme | Not calculated |
| (2S)-7-[[6-O-(6-Déoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-méthoxyphényl)-4H-1-benzopyrane-4-one Source : Citrus sinensis - fruit | 100 milligramme | Not calculated |
| Extrait de pépins de raisin Source : Vitis vinifera - Graine Extract : Matériel brut sec Extraction ratio : 15:1 Dry plant equivalent : 375 milligramme Potency : 95 % Proanthocyanidins | 25 milligramme | Not calculated |
| Ginkgo biloba Source : Feuille Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 1,500 milligramme Potency : 6 % Terpene lactones | 30 milligramme | Not calculated |
| Pinus massoniana Source : Écorce (tige) Potency : 95 % Proanthocyanidins | 25 milligramme | Not calculated |
| Aesculus hippocastanum Source : Graine(s) Potency : 20 % Aescin | 50 milligramme | Not calculated |
| Ruscus aculeatus Source : Rhizome Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 300 milligramme Potency : 10 % Ruscogenin | 30 milligramme | Not calculated |
Non-medicinal ingredients
Gélatine, Silice pyrogénée, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 1 day |
Uses authorised in Canada
Source of antioxidant. An antioxidant. Source of antioxidants for the maintenance of good health. Used in Herbal medicine as a capillary/blood vessel protectant; Source of/An antioxidant that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
If you are pregnant or breastfeeding, do not use.
- Précautions et mises en garde
If you are taking any prescription medication, consult a health care practitioner prior to use. Some people may experience headache, dizziness, gastric irritation, or itchiness. Consult a health care practitioner prior to use if you are taking medications for diabetes, high blood pressure, or seizures. Do not use if you are taking health products that affect blood coagulation (e.g. blood thinners, clotting factor replacements, acetylsalicylic acid, ibuprofen, fish oils, Vitamin E) as this may increase the risk of spontaneous bleeding.
Source
Official Health Canada record, licence 80086973
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.